GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $456,000 | -7.5% | 10,480 | -7.4% | 0.04% | +9.1% |
| Q1 2022 | $493,000 | -9.2% | 11,315 | -8.1% | 0.03% | -5.7% |
| Q4 2021 | $543,000 | -7.2% | 12,307 | -19.6% | 0.04% | -10.3% |
| Q3 2021 | $585,000 | +5.8% | 15,311 | +10.2% | 0.04% | -2.5% |
| Q2 2021 | $553,000 | -15.4% | 13,891 | -24.2% | 0.04% | -21.6% |
| Q1 2021 | $654,000 | -41.3% | 18,322 | -39.5% | 0.05% | -43.3% |
| Q4 2020 | $1,114,000 | -6.3% | 30,280 | -4.1% | 0.09% | -24.4% |
| Q3 2020 | $1,189,000 | -15.3% | 31,581 | -8.2% | 0.12% | -21.7% |
| Q2 2020 | $1,404,000 | -1.5% | 34,413 | -8.5% | 0.15% | -18.3% |
| Q1 2020 | $1,426,000 | -20.3% | 37,623 | -1.2% | 0.19% | 0.0% |
| Q4 2019 | $1,790,000 | +8.0% | 38,093 | -1.9% | 0.19% | -0.5% |
| Q3 2019 | $1,657,000 | +3.6% | 38,832 | -2.8% | 0.19% | +1.6% |
| Q2 2019 | $1,599,000 | -10.7% | 39,955 | -6.8% | 0.18% | -12.8% |
| Q1 2019 | $1,791,000 | -1.5% | 42,850 | -10.0% | 0.21% | -15.6% |
| Q4 2018 | $1,818,000 | -10.7% | 47,586 | -6.1% | 0.25% | -1.2% |
| Q3 2018 | $2,035,000 | -3.9% | 50,670 | -3.6% | 0.25% | -12.2% |
| Q2 2018 | $2,118,000 | +0.8% | 52,552 | -2.3% | 0.29% | +2.5% |
| Q1 2018 | $2,102,000 | +10.6% | 53,812 | +0.4% | 0.28% | +3.3% |
| Q4 2017 | $1,901,000 | -25.7% | 53,585 | -15.0% | 0.27% | -31.0% |
| Q3 2017 | $2,559,000 | -17.7% | 63,026 | -12.6% | 0.39% | -23.6% |
| Q2 2017 | $3,109,000 | +5.4% | 72,111 | +3.1% | 0.52% | +3.0% |
| Q1 2017 | $2,949,000 | +17.7% | 69,947 | +7.5% | 0.50% | +14.6% |
| Q4 2016 | $2,506,000 | -8.3% | 65,067 | +2.7% | 0.44% | -12.1% |
| Q3 2016 | $2,733,000 | +2.3% | 63,356 | +2.8% | 0.50% | -1.4% |
| Q2 2016 | $2,672,000 | +12.5% | 61,646 | +5.2% | 0.50% | +5.4% |
| Q1 2016 | $2,376,000 | +5.6% | 58,582 | +5.1% | 0.48% | +0.6% |
| Q4 2015 | $2,249,000 | +14.7% | 55,727 | +9.3% | 0.48% | +9.4% |
| Q3 2015 | $1,961,000 | -5.4% | 51,005 | +2.5% | 0.43% | +0.9% |
| Q2 2015 | $2,072,000 | +25.3% | 49,758 | +38.9% | 0.43% | +25.0% |
| Q1 2015 | $1,653,000 | +101.1% | 35,824 | +86.3% | 0.34% | +97.7% |
| Q4 2014 | $822,000 | +18.1% | 19,228 | +27.0% | 0.17% | +15.2% |
| Q3 2014 | $696,000 | -13.9% | 15,141 | +0.2% | 0.15% | -12.7% |
| Q2 2014 | $808,000 | +0.7% | 15,108 | +0.7% | 0.17% | -2.3% |
| Q1 2014 | $802,000 | +0.8% | 15,008 | +0.7% | 0.18% | -7.3% |
| Q4 2013 | $796,000 | +5.0% | 14,908 | -1.4% | 0.19% | -4.5% |
| Q3 2013 | $758,000 | 0.0% | 15,113 | -0.3% | 0.20% | -5.2% |
| Q2 2013 | $758,000 | – | 15,163 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |